Acute and Chronic Effects of Gepirone and Fluoxetine in Rats Tested in the Elevated Plus-maze
- 1 February 2000
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 65 (2) , 209-216
- https://doi.org/10.1016/s0091-3057(99)00193-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- SEROTONERGIC SYSTEMSPsychiatric Clinics of North America, 1997
- Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-mazeBehavioural Pharmacology, 1997
- Risk Assessment Behaviour: Evaluation of Utility in the Study of 5-HT-Related Drugs in the Rat Elevated Plus-Maze TestPharmacology Biochemistry and Behavior, 1997
- The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω 1) selective, benzodiazepine receptor ligandsPsychopharmacology, 1996
- 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of researchPharmacology & Therapeutics, 1995
- Ethopharmacological analysis of rat behavior on the elevated plus-mazePharmacology Biochemistry and Behavior, 1994
- Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidolPsychopharmacology, 1994
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987
- Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brainSynapse, 1987
- Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviourNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984